✦ LIBER ✦

Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?

✍ Scribed by B. Seyfarth; R. Kuse; R. Sonnen; B. Glass; N. Schmitz; P. Dreger

Publisher: Springer
Year: 2001
Tongue: English
Weight: 71 KB
Volume: 80
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770100321

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outpatient autologous hematopoietic stem

Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma

✍ Chantal Leger; Mitchell Sabloff; Sheryl McDiarmid; Isabelle Bence-Bruckler; Harr 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 202 KB

Peripheral blood stem cell CD34+ autolog

Peripheral blood stem cell CD34+ autologous transplant in relapsed follicular lymphoma

✍ G. H. Marin; L. Dal Cortivo; J. M. Cayuela; J. P. Marolleau; P. Pautier; I. Coje 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 156 KB

Factors affecting stem cell mobilization

Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation

✍ Zübeyde Nur Özkurt; Zeynep Arzu Yeǧin; Elif Suyanı; Şahika Zeynep Akı; Kadir Aca 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

## Abstract High‐dose chemotherapy with autologous stem cell transplantation (ASCT) is curative treatment in various hematologic malignancies. Mobilization and collection of peripheral blood stem cell is the essential part of ASCT. The aim of this study was to evaluate the effectiveness of various

Patterns and outcome of relapse after au

Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma

✍ Sascha Dietrich; Blanca Tielesch; Michael Rieger; Maike Nickelsen; Christiane Po 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

## Abstract ## BACKGROUND: Autologous stem cell transplantation (autoSCT) has improved the outcome of patients with mantle cell lymphoma (MCL) considerably. However, little is known about the patterns and outcome of MCL recurrence after autoSCT. ## METHODS: The authors conducted a retrospective

High-dose chemotherapy and autologous st

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival

✍ Min Kyoung Kim; Shin Kim; Sung Sook Lee; Sun Jin Sym; Dae Ho Lee; Seongsoo Jang; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 167 KB

Symptom burden after autologous stem cel

Symptom burden after autologous stem cell transplantation for multiple myeloma

✍ Erica Campagnaro; Rima Saliba; Sergio Giralt; Linda Roden; Floralyn Mendoza; Ana 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract ## BACKGROUND Multiple myeloma (MM) is the most common indication for high‐dose chemotherapy with autologous stem cell transplantation (ASCT) in the U.S. and can be associated with substantial morbidity. Thorough assessment and understanding of symptoms and risk factors for symptom dev